Air pollution from road traffic and systemic inflammation in adults : a cross-sectional analysis in the European ESCAPE project by Lanki, Timo et al.
Environmental Health Perspectives • volume 123 | number 8 | August 2015 785
ResearchA Section 508–conformant HTML version of this article  is available at http://dx.doi.org/10.1289/ehp.1408224. 
Introduction
Exposure to ambient particulate matter 
pollution (PM) affects both respiratory 
and cardiovascular health, and is a major 
contributor to the global burden of disease 
(Lim et al. 2012). One of the main sources 
of particulate air pollution is road traffic. 
Tailpipe exhaust is a source of fine combus-
tion particles (soot), which are associated 
with cardio respiratory health effects and 
premature mortality (Janssen et al. 2012). 
However, road traffic also produces road dust 
consisting mainly of coarse particles. There 
is increasing evidence on the harmfulness of 
coarse particulate matter (Brunekreef and 
Forsberg 2005).
Ischemic heart disease is the leading 
contribu tor to the burden of disease worldwide, 
and stroke is ranked third (Murray et al. 2012). 
An American Heart Association Statement has 
concluded that exposure to fine particulate air 
pollution is likely to be causally linked to cardio-
vascular disease (CVD) (Brook et al. 2010). 
Because of its ubiquitous presence, particulate 
air pollution is a relevant trigger of myocardial 
infarction on a population level (Nawrot et al. 
2011). There is less, but increasing, evidence on 
the associations between long-term exposure to 
traffic-related air pollutants and the incidence 
of CVD (Brook et al. 2010).
It has been hypothesized that increased 
systemic inflammation—a risk factor for, as 
well as a consequence of, atherosclerosis—is 
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Background: Exposure to particulate matter air pollution (PM) has been associated with 
cardiovascular diseases.
oBjectives: In this study we evaluated whether annual exposure to ambient air pollution is 
associated with systemic inflammation, which is hypothesized to be an intermediate step to 
cardiovascular disease.
Methods: Six cohorts of adults from Central and Northern Europe were used in this cross-
sectional study as part of the larger ESCAPE project (European Study of Cohorts for Air Pollution 
Effects). Data on levels of blood markers for systemic inflammation—high-sensitivity C-reactive 
protein (CRP) and fibrinogen—were available for 22,561 and 17,428 persons, respectively. Land 
use regression models were used to estimate cohort participants’ long-term exposure to various size 
fractions of PM, soot, and nitrogen oxides (NOx). In addition, traffic intensity on the closest street 
and traffic load within 100 m from home were used as indicators of traffic air pollution exposure.
results: Particulate air pollution was not associated with systemic inflammation. However, cohort 
participants living on a busy (> 10,000 vehicles/day) road had elevated CRP values (10.2%; 95% CI: 
2.4, 18.8%, compared with persons living on a quiet residential street with < 1,000 vehicles/day). 
Annual NOx concentration was also positively associated with levels of CRP (3.2%; 95% CI: 0.3, 6.1 
per 20 μg/m3), but the effect estimate was more sensitive to model adjustments. For fibrinogen, no 
consistent associations were observed.
conclusions: Living close to busy traffic was associated with increased CRP concentrations, 
a known risk factor for cardiovascular diseases. However, it remains unclear which specific air 
 pollutants are responsible for the association.
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the main underlying mechanism linking 
long-term PM exposure to incidence of CVD 
(Brook et al. 2010). A number of studies 
have associated daily variation in PM with 
short-term changes in the concentrations of 
circulating inflammatory markers (Brook et al. 
2010). However, it is not known whether 
recurrent high short-term exposures may 
also lead to chronic and partly self-sustained 
systemic inflammation. Associations between 
long-term within-city variation in PM, typi-
cally driven by traffic emissions, and systemic 
inflammation have been evaluated only 
in a few population-level studies, and with 
conflicting results (Chuang et al. 2011; Forbes 
et al. 2009; Hoffmann et al. 2009; Panasevich 
et al. 2009; Schwartz 2001). Therefore, we 
evaluated within the large multi-center 
ESCAPE project (European Study of Cohorts 
for Air Pollution Effects) the associations 
of long-term exposure to traffic and traffic-
related air pollution with high-sensitivity 
C-reactive protein (CRP), a clinically estab-
lished sensitive marker of systemic inflamma-
tion (Emerging Risk Factors Collaboration 
et al. 2010), and fibrinogen, a hemostatic 
factor with proinflammatory properties.
Methods
Study population. The ESCAPE project linked 
data from existing cohorts in different parts 
of Europe with modeled long-term residen-
tial air pollution concentrations. The studies 
were approved by the local ethical committees 
and conducted according to the guidelines 
laid down in the Declaration of Helsinki. All 
data were collected in accordance with the 
Declaration of Helsinki, and all participants 
gave an informed consent before the study. 
Data on blood levels of high-sensitivity CRP 
was available for five cohorts in Northern 
and Central Europe: the National FINRISK 
study in Finland, KORA (Cooperative Health 
Research in the Region of Augsburg) and 
HNR (Heinz Nixdorf Recall) in Germany, 
SAPALDIA (Swiss Study on Air Pollution 
and Lung and Heart Disease In Adults) in 
Switzerland, and TwinGene in Sweden. For 
the analyses of fibrinogen, four cohorts were 
available: FINRISK, KORA, HNR, and the 
“60-year-olds” study in Sweden. Descriptive 
statistics of these cohorts are presented in 
Table 1. See Supplemental Material, “Cohort 
descriptions” and “Biochemical measure-
ments,” for further information on the 
cohorts, as well as the methods for estimating 
CRP and fibrinogen.
Exposure data. Air pollution measure-
ments and modeling followed common 
study protocols (ESCAPE 2008) and 
were coordinated by the Institute for Risk 
Assessment Sciences of Utrecht University. 
Concentrations of several size fractions of 
particulate air pollution (PM2.5, aerody-
namic diameter < 2.5 μm; PM10, < 10 μm; 
PMcoarse, 2.5 μm ≤ diameter < 10 μm), black 
carbon (PM2.5 absorbance), that is, soot, 
and nitrogen oxides (NO2 and NOx) were 
measured (Cyrys et al. 2012; Eeftens et al. 
2012b). In each study area, pollutants were 
measured in different locations for 2 weeks 
during winter, summer, and an inter-
mediate season; that is, 6 weeks altogether 
in an approximately 1-year period (starting 
from autumn 2008 for KORA, HNR, and 
SAPALDIA; from winter 2008 for TwinGene 
and 60-year-olds study; and from winter 
2010 for FINRISK). At the same time, 
pollutants were measured continuously for 
1 year at one regional or urban background 
site in each study area as described by Eeftens 
et al. (2012b). Based on these measurements, 
annual outdoor concentrations of air pollu-
tion were modeled at the participants’ home 
addresses using land use regression (LUR) 
models (Beelen et al. 2013; Eeftens et al. 
2012a). The models were developed for each 
cohort based on a common manual (ESCAPE 
2008). A large number of potential predic-
tors of air pollution concentrations derived 
from geographic information systems (e.g., 
traffic intensity, population density, forms 
of land use) were tested in the models with 
an aim to maximize explained variability. In 
SAPALDIA, models for PM were only avail-
able for one study area (Lugano, Switzerland). 
Measurements of air pollution for modeling 
purposes were conducted later (2008–2011) 
than the collection of blood samples 
(1994–2008). Therefore, historical air pollu-
tion concentrations were extrapolated for 
sensitivity analyses using data from routine 
monitoring network site(s) as explained by 
Beelen et al. (2014).
In addition to modeled air pollution 
concentration, two indices of exposure to 
traffic were used: traffic intensity (vehicles/day) 
at the road nearest to the participant’s resi-
dence, and traffic load on major roads within 
100 m of the residence (measured as the 
product of traffic intensity and the length of 
major road fragments within a 100-m buffer). 
Databases on traffic intensity were constructed 
for each cohort based on measurements 
conducted by county- or municipal-level 
authorities (Eeftens et al. 2012a). The traffic 
indices were always included in the statis-
tical models together with background NO2 
concentrations. Information on the traffic 
intensity at the nearest road was not available 
for the HNR cohort.
Data analyses. One blood sample per 
person was available for the analyses, taken 
at the baseline visit except for SAPALDIA 
(first follow-up visit). High-sensitivity CRP 
and fibrinogen on continuous scales were 
used for the current cross-sectional analyses. 
Based on the distribution of inflammatory 
blood marker concentrations and model 
residuals, the (natural) logarithmic value of 
CRP concentrations was used in the analyses, 
whereas fibrinogen concentrations were not 
transformed. Linear regression models in SAS 
(SAS Institute Inc.) and STATA (StataCorp) 
software were used for the analyses. In the 
meta-analyses, cohort-specific effects were 
treated as having a random component apart 
from sampling error, and pooled using the 
empirical Bayes method. Heterogeneity of 
the cohort-specific estimates was estimated 
using Cochrane’s Q test. Effect estimates 
are presented as percent difference from the 
outcome mean together with 95% confi-
dence interval (CI), and are calculated for an 
increase of 5 μg/m3 in PM2.5 and PMcoarse, 
10 μg/m3 in PM10 and NO2, 20 μg/m3 in 
NOx, and 1 × 10–5/m in PM2.5 absorbance. 
An association was deemed present when it 
was statistically significant (p < 0.05).
Confounders in the statistical models were 
selected a priori based on literature on the 
determinants of CRP and fibrinogen concen-
trations. Four different regression models were 
Table 1. Descriptive statistics for the study cohorts.
Study cohort (country) Time of baseline visit
Agea Sexa BMIa Smokinga C-reactive protein Fibrinogen
Range 
(years)
Average 
(years)
Female 
(%)
Average 
(kg/m2)
Current 
(%)
n of 
samples
Average ± SD 
(mg/L)
n of 
samples
Average ± SD 
(g/L)
KORA (Germany) 1994–1995, 2000–2001 25–74 50.2 50.1 27.2 23.9 7,137 2.7 ± 4.9 7,151 2.76 ± 0.67
HNR (Germany) 2000–2003 45–76 59.5 49.9 27.9 23.3 4,492 3.1 ± 9.0 4,444 3.3 ± 0.8
SAPALDIA (Switzerland) 2002 18–60 53.8 52.7 25.5 27.7 1,688 2.1 ± 3.2 NA NA
FINRISK (Finland) 1997, 2002, 2007 25–64 48.9 52.4 26.6 28.3 7,627 2.3 ± 4.5 2,044 3.55 ± 0.81
TwinGene (Sweden) 2004–2008 47–90 64.2 56.2 25.2 19.1 1,617 2.8 ± 4.9 NA NA
60-year-olds (Sweden) 1997–1999 60 60.4 52 26.8 20.8  NA  NA 3,789 3.02 ± 0.77
Abbreviations: BMI, body mass index; NA, not available.
aNumbers are based on participants with CRP measurements (except for 60-year-olds cohort). Descriptive statistics were similar when limited to participants with fibrinogen data 
(data not shown).
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used to calculate the effect estimates. All these 
models included, in addition to exposure vari-
ables, an indicator variable for baseline visit for 
FINRISK and KORA, which had more than 
one recruitment period, and an area indicator 
for FINRISK, which consisted of two clearly 
separate study areas. Additional variables 
controlled for in the first regression model (the 
crude model) were age and sex. The second 
model (the main model) also included educa-
tion (primary school or less, up to secondary 
school or equivalent, university degree), body 
mass index, smoking status (current smoker, 
ex-smoker, never smoker), physical activity 
(≤ 3 times/month, once a week, 2–3 times/
week, > 3 times/week), and alcohol intake 
(number of drinks per week; 0, 1–3, 4–6, > 6). 
Effect estimates were also calculated using an 
extended model, which included additional 
covariates not available in all cohorts (alcohol 
intake excluding wine, wine intake, household 
income, fish intake, fruit intake, meat intake, 
CVD, diabetes, arthritis, ulcerative colitis, 
passive smoking).
The fourth model was a mixed model 
that included the same covariates as the main 
model, but also included neighborhood level 
as a random effect to take into account possible 
spatial clustering of observations. Depending 
on data availability for each cohort, neighbor-
hoods either were defined as grids or were 
based on ZIP code areas. We assumed that the 
effect of neighborhood on health was mainly 
attributable to area level socioeconomic status. 
Therefore, area level median household income 
or unemployment rate were included in the 
model as fixed effects.
Effect modification by obesity (cutpoint, 
30 kg/m2 for body mass index) and sex was 
evaluated by adding an interaction term in the 
main model. In addition, a number of sensi-
tivity analyses were conducted using the main 
model: exclusion of participants with high 
(> 10 mg/L) CRP values that may indicate a 
current bacterial infection, exclusion of study 
participants who moved residence during the 
2 years before blood draw (information not 
available for KORA and for HNR participants 
from Bochum, Germany; see Supplemental 
Material, “Cohort descriptions”), use of 
back-extrapolated concentrations of NOx, 
NO2, and PM10 (in cohorts where changes 
over time in concentrations had occurred), 
inclusion of indicators for medication use 
(statins and antihypertensives), and finally 
inclusion of traffic noise for a subset of data 
in each center [data available only for larger 
population agglomerates as defined by the 
European Union (EU), no data available 
for SAPALDIA]. Traffic noise was modeled 
according to the guidelines of the EU noise 
directive (EU 2002). When using meta-
analyses to generate combined effect estimates 
for sensitivity analyses, we substituted effect 
estimates from the main model for cohorts 
missing data for the sensitivity analyses.
Results
In the participating cohorts, the average age of 
the participants ranged from 49 to 64 years, 
and the proportion of current smokers ranged 
from 19 to 28% (Table 1). All cohorts 
consisted of approximately 50% women. 
There were altogether 22,561 participants 
with measures of CRP, and 17,428 samples 
of fibrinogen. Consistently across the cohorts, 
the standard deviation was much larger for 
CRP than for fibrinogen.
Modeled air pollution concentrations 
were the lowest in the Northern cohorts, 
in Finland and Sweden (Table 2). The 
highest traffic loads were observed near 
(within 100 m) the homes of the HNR and 
SAPALDIA study  participants, and the lowest 
in the KORA cohort.
In the pooled analyses using the main 
model, CRP serum levels were positively asso-
ciated with annual NOx concentration (3.2%; 
95% CI: 0.3, 6.1 per 20-μg/m3 increase in 
NOx) and traffic intensity at the nearest road 
(10.2%; 95% CI: 2.4, 18.6 for the highest 
category, i.e., > 10,000 vehicles/day; reference 
category < 1,000 vehicles/day) without 
evidence of significant heterogeneity between 
ESCAPE cohorts (Table 3, Figure 1). 
Categories of traffic load within 100 m 
from residence were not consistently associ-
ated with CRP. Inclusion of an extended 
set of individual level confounders (Table 3, 
Extended model) had only minor effects on 
the estimates. When area-level confounding 
was taken into account, the effect estimate 
for NOx decreased and was no longer statisti-
cally significant (2.5%; 95% CI: –0.6, 5.6) 
(Table 3, Area-level model). In contrast, effect 
estimates for traffic intensity at the nearest road 
were not affected. Particulate air pollution, 
including black carbon, and NO2 were not 
associated with CRP in the pooled analyses. 
However, in cohort-specific analyses, high 
effect estimates were observed for PM2.5 in the 
German cohorts: statistically nonsignificant for 
KORA (12.9%; 95% CI: –1.4, 29.2%; per 
5-μg/m3 increase in PM2.5), but significant 
for HNR (16.1%; 95% CI: 0.5, 34.1%) (see 
Supplemental Material, Figure S1).
In the pooled analyses for fibrinogen, 
borderline significant (p < 0.1) positive 
associa tions were observed for NOx and 
traffic load within 100 m (in the two highest 
categories) without evidence of heterogeneity 
(Table 3, Figure 1). Slightly decreased effect 
estimates for traffic load were observed when 
the extended model was used (Table 3). 
Adding area-level confounders in the models 
did not affect the results. Other air pollutants 
were not associated with fibrinogen. However, 
in cohort-specific analyses, high effect esti-
mates were observed for NO2 in the German 
cohorts: statistically significant for KORA 
(1.6%; 95% CI: 0.5, 2.7% per 10-μg/m3 
increase in NO2), but nonsignificant for 
HNR (1.2%; 95% CI: –0.2, 2.7%) (see 
Supplemental Material, Figure S2). Finally, 
the middle category of traffic intensity was 
positively associated with fibrinogen in the 
pooled analyses, but there was no evidence of 
association for the other categories.
Estimated effects of air pollution or traffic 
were not modified by obesity or sex: The confi-
dence intervals were overlapping in the pooled 
analyses, and no consistent patterns were 
observed in the cohort-specific analyses (data 
not shown). Inclusion of environmental noise 
in the main model for CRP increased effect 
estimates for traffic intensity in the two highest 
categories (8.2%; 95% CI: 1.0, 15.9, and 
11.9%; 95% CI: 3.4, 21.2, respectively) (see 
Supplemental Material, Table S1). Inclusion 
of information on statin use in the model and 
Table 2. Descriptive statistics for modeled annual residential air pollution concentrations and indices of traffic intensity.
Study cohort
PM2.5 
(μg/m3)
PM10 
(μg/m3)
PMcoarse 
(μg/m3)
PM2.5 absorbance  
(1 × 10–5/m)
NO2 
(μg/m3)
NOx 
(μg/m3)
Traffic, nearest 
roada  
(vehicles/day)
Traffic, within  
100 mb  
(vehicles/day × m)
Avg
5th 
Pctl
95th 
Pctl Avg
5th 
Pctl
95th 
Pctl Avg
5th 
Pctl
95th 
Pctl Avg
5th 
Pctl
95th 
Pctl Avg
5th 
Pctl
95th 
Pctl Avg
5th 
Pctl
95th 
Pctl Avg
95th 
Pctl Avg
95th 
Pctl
KORA 13.6 12.5 15.3 20.3 16.5 24.3 6.2 4.9 8.4 1.7 1.5 2 18.7 13.7 25.9 32.6 23.8 47.1 1,600 8,500 434,000 2,790,000
HNR 18.4 16.9 20.4 27.8 25.3 31.6 10 7.3 12.4 1.6 1.2 2.2 30.3 23.4 38.7 50.9 33.6 71.9 NA NA 1,124,000 4,432,000
SAPALDIA 17.1 14.7 19.9 23.7 19.8 27.4 6.7 4.9 8.6 2 1.3 2.5 27.8 17.1 37.9 46.7 24.0 69.5 3,520 15,500 945,000 4,170,000
FINRISK 7.7 5.6 9.1 14.1 9.5 19.9 6.7 3.9 11 1.3 1.1 1.6 15.4 8.7 24.2 24.4 13.6 41.2 1,700 9,600 638,000 3,750,000
TwinGene 7.2 4.8 9.2 14.8 6.5 20.5 7.2 1.0 11.8 0.6 0.4 0.9 10.8 6.7 19.9 18.7 11.4 39.4 1,500 6,400 570,000 3,300,000
60-year-olds 7.3 4.9 9.2 15.0 6.8 20.6 7.3 1.3 11.8 0.6 0.4 1 10.7 6.5 20.3 18.6 12.0 39.3 1,400 6,300 519,000 3,090,000
Abbreviations: Avg, average; NA, not available; Pctl, percentile.
aTraffic intensity on the road nearest to the residence. bTraffic load on major roads within 100 m from the residence.
Lanki et al.
788 volume 123 | number 8 | August 2015 • Environmental Health Perspectives
exclusion of persons who had recently moved 
led to decreased estimated effects of NOx on 
CRP (2.5%; 95% CI: –0.4, 5.4, and 2.3%; 
95% CI: –1.0, 5.8, respectively).
After exclusion of unusually high CRP 
values (237 observations for KORA, 181 for 
HNR, 47 for SAPALDIA, 257 for FINRISK, 
and 62 for TwinGene), effect estimates 
increased for PMcoarse (from 3.0%; 95% CI: 
–0.7, 6.8 to 6.4%; 95% CI: –0.4, 13.5% 
for a 5-μg/m3 increase).There were only 
minor changes in the effect estimates, when 
back-extrapolated air pollution levels were 
used in the models for CRP and fibrinogen 
(data not shown). In general, sensitivity 
analyses had only minor effects on the effect 
estimates for fibrinogen (see Supplemental 
Material, Table S1).
Discussion
In this European multi-center study, modeled 
annual particulate air pollution concentra-
tions were not associated with systemic 
inflammation. However, high traffic intensity 
on the road nearest to home was associated 
with increased levels of high-sensitivity CRP, 
an established marker for systemic inflamma-
tion. In the main analyses, long-term exposure 
to NOx, an indicator for vehicle exhaust, 
was also associated with CRP serum levels. 
However, the effect estimate was more sensi-
tive to further adjustments in the model, 
such as inclusion of area-level confounders. 
Fibrinogen was not consistently associ-
ated with air pollution, and there was only 
limited support for a positive association with 
traffic exposure.
CRP is an acute-phase reactant that has 
been shown in many cohort studies to be a 
reliable measure of underlying systemic inflam-
mation and a predictor of future myocardial 
infarction and stroke (Danesh et al. 2004; 
Emerging Risk Factors Collaboration et al. 
2010). In the present study, NOx was the 
only pollutant that was positively associated 
with CRP in the analyses performed with 
the a priori–selected main model. However, 
the association between NOx and CRP 
was somewhat sensitive to adjustments in 
the models, such as inclusion of area-level 
confounders or information on statin use or 
moving history. Therefore, further studies are 
needed to confirm the suggestive association. 
Furthermore, it is possible that nitrogen oxides 
are not causally related to systemic inflamma-
tion, but that they rather represent markers for 
traffic-related air pollution mixture, including 
ultrafine particles, volatile organic compounds, 
and traffic-related PM2.5.
In the present study, no evidence of an 
effect was found for soot, measured as PM2.5 
absorbance, which is considered to be a key 
component of the near-road traffic-related 
pollution mixture. One reason for this might 
be that soot is stable in the atmosphere and is 
therefore associated not only with fresh but 
also with aged vehicle exhaust, which may 
be less toxic due to secondary atmospheric 
reactions. On the other hand, NOx is a better 
Table 3. Associations of air pollution and indices of traffic intensity with CRP and fibrinogen in the pooled analyses. 
Exposures
Crude modela Main modelb Extended modelc Area-level modeld
% Diffe (95% CI) pHeterf % Diffe (95% CI) pHeterf % Diffe (95% CI) pHeterf % Diffe (95% CI) pHeterf
CRP
PM2.5 9.4 (–9.7, 32.5) 0.00 2.4 (–7.5, 13.4) 0.05 2.3 (–6.4, 11.7) 0.11 –0.3 (–9.0, 9.2) 0.14
PM10 2.2 (–7.6, 12.9) 0.05 1.2 (–3.8, 6.4) 0.90 0.7 (–4.3, 5.9) 0.94 0.2 (–4.9, 5.6) 0.76
PMcoarse 2.8 (–2.3, 8.2) 0.21 3.0 (–0.7, 6.8) 0.53 2.4 (–1.2, 6.1) 0.66 2.4 (–1.6, 6.5) 0.35
PM2.5 absorbance 3.2 (–6.9, 14.4) 0.01 0.4 (–5.2, 6.4) 0.73 0.0 (–5.5, 5.9) 0.86 –2.5 (–8.4, 3.6) 0.78
NO2 2.2 (–4.3, 9.2) 0.00 2.1 (–0.8, 5.1) 0.72 2.0 (–0.9, 4.9) 0.82 1.4 (–1.7, 4.6) 0.70
NOx 3.2 (–2.5, 9.2) 0.00 3.2 (0.3, 6.1)** 0.95 2.9 (0.1, 5.9)** 0.99 2.5 (–0.6, 5.6) 0.94
Traffic intensity at the nearest road (vehicles/day)
< 1,000 Reference Reference Reference Reference
1,000–5,000 –0.8 (–5.9, 4.5) 0.81 –1.7 (–6.3, 3.2) 0.69 –2.0 (–6.6, 2.8) 0.81 –1.6 (–6.2, 3.3) 0.66
5,000–10,000 6.3 (–0.9, 14.1)* 0.57 5.5 (–1.2, 12.6) 0.42 4.5 (–2.0, 11.6) 0.55 5.1 (–2.7, 13.6) 0.35
> 10,000 12.8 (4.2, 22.2)** 0.84 10.2 (2.4, 18.6)** 0.77 9.8 (2.1, 18.2)** 0.84 10.2 (2.4, 18.6)** 0.76
Traffic load within 100 m on major roads (vehicles/day × m)
< 500,000 Reference Reference Reference Reference
500,000–1,500,000 0.2 (–7.9, 9.0) 0.15 1.4 (–3.0, 6.0) 0.41 1.1 (–3.3, 5.7) 0.59 1.3 (–3.3, 6.1) 0.39
1,500,000–3,000,000 3.6 (–1.6, 9.1) 0.66 1.8 (–3.0, 6.8) 0.51 1.6 (–3.1, 6.5) 0.72 1.5 (–3.3, 6.5) 0.41
> 3,000,000 5.3 (–1.8, 13.0) 0.23 2.6 (–3.4, 9.0) 0.29 2.0 (–3.9, 8.3) 0.30 2.1 (–3.7, 8.3) 0.32
Fibrinogen
PM2.5 2.8 (0.3, 5.3)** 0.09 0.5 (–1.1, 2.0) 0.66 0.2 (–1.3, 1.8) 0.77 0.4 (–1.3, 2.0) 0.96
PM10 0.5 (–2.3, 3.2) 0.01 0.1 (–1.4, 1.8) 0.18 0.0 (–1.4, 1.4) 0.27 –0.2 (–1.4, 1.0) 0.39
PMcoarse –0.0 (–1.7, 1.6) 0.03 –0.1 (–1.2, 0.9) 0.24 –0.3 (–1.2, 0.6) 0.37 –0.5 (–1.4, 0.4) 0.80
PM2.5 absorbance 1.5 (–0.4, 3.5) 0.25 0.3 (–1.2, 1.9) 0.36 0.1 (–1.3, 1.6) 0.49 –0.5 (–2.0, 1.1) 0.61
NO2 0.8 (–1.2, 2.8) 0.00 0.5 (–0.8, 1.8) 0.04 0.5 (–0.7, 1.6) 0.10 0.4 (–0.6, 1.3) 0.30
NOx 0.9 (–0.9, 2.7) 0.00 0.7 (–0.4, 1.8) 0.08 0.6 (–0.5, 1.6) 0.13 0.5 (–0.4, 1.3) 0.31
Traffic intensity at the nearest road (vehicles/day)
< 1,000 Reference Reference Reference Reference
1,000–5,000 0.5 (–0.7, 1.8) 0.43 0.2 (–1.5, 1.8) 0.28 0.0 (–1.2, 1.3) 0.48 0.1 (–1.4, 1.7) 0.29
5,000–10,000 1.8 (0.0, 3.6)* 0.93 1.8 (0.1, 3.5)** 0.99 1.6 (–0.1, 3.3)* 0.93 1.9 (0.1, 3.6)** 0.99
> 10,000 1.3 (–0.7, 3.3) 0.40 0.9 (–1.0, 2.8) 0.84 0.6 (–1.3, 2.5) 0.75 0.9 (–1.1, 2.8) 0.85
Traffic load within 100 m on major roads (vehicles/day × m)
< 500,000 Reference Reference Reference Reference
500,000–1,500,000 0.2 (–1.3, 1.7) 0.18 0.3 (–0.8, 1.4) 0.39 0.1 (–0.9, 1.2) 0.37 0.2 (–1.0, 1.4) 0.32
1,500,000–3,000,000 1.4 (0.2, 2.7)** 0.87 1.0 (–0.2, 2.2)* 0.87 0.9 (–0.3, 2.1) 0.86 1.0 (–0.2, 2.2) 0.86
> 3,000,000 1.9 (0.3, 3.5)** 0.35 1.2 (–0.2, 2.6)* 0.59 1.1 (–0.2, 2.5) 0.64 1.2 (–0.2, 2.6)* 0.57
Effect estimates were calculated for a change of 5 μg/m3 in PM2.5 and PMcoarse, 10 μg/m3 in PM10 and NO2, 20 μg/m3 in NOx, and 1 x 10–5/m in PM2.5 absorbance.
aModel was adjusted for age, sex, baseline visit (KORA and FINRISK), study area (FINRISK). bModel was adjusted for age, sex, baseline visit (KORA and FINRISK), study area (FINRISK), 
education, body mass index, smoking status, physical activity, alcohol intake. cModel was adjusted for age, sex, baseline visit (KORA and FINRISK), study area (FINRISK), education, 
body mass index, smoking status, physical activity in all cohorts, and for wine intake, intake of other types of alcohol, household income, fish intake, fruit intake, meat intake, CVD, 
diabetes, arthritis, colitis ulcerosa, passive smoking in cohorts where the data available. dMixed model (neighborhood as a random effect) was adjusted for age, sex, baseline visit 
(KORA and FINRISK), study area (FINRISK), education, body mass index, smoking status, physical activity, and area level household income or unemployment rate. ePercent difference. 
fp-Value for heterogeneity. *Effect estimates with p-values < 0.1.**Effect estimates with p-values < 0.05. 
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marker for vehicle exhausts than soot, which 
also has other (combustion) sources such as 
residential wood combustion (Healy et al. 
2012; Janssen et al. 2012).
Another traffic-related pollutant is the 
coarse size fraction of particulate matter, 
which forms the major part of road dust. 
Road dust is rich in earth minerals (wear 
of road surface), transition metals (wear of 
brakes and clutch), and biological material 
(pollen fragments, bacteria). All these compo-
nents have been shown in toxicological 
studies to have considerable proinflammatory 
potential (Camatini et al. 2012; Jalava et al. 
2009; Schwarze et al. 2007). In the present 
study, effect estimates for coarse particles were 
consistently positive, but statistical signifi-
cance was not reached in the main analyses. 
This could be attributable partly to exposure 
misclassification: LUR models predicted less 
of the variance of outdoor concentrations 
of PMcoarse (average R2 of models = 71%) 
than of NOx (R2 = 86%) (Beelen et al. 2013; 
Eeftens et al. 2012a).
In the pooled analyses, markers of inflam-
mation were not associated with PM2.5 or 
PM10, the spatial variation of which is less 
strongly associated with road traffic than 
that of NOx (Eeftens et al. 2012b). It can be 
speculated that PM2.5 and PM10 contain some 
components that are less toxic than pollu-
tion mixture near traffic. Only a few epide-
miological studies have previously evaluated 
associations between long-term exposure to air 
pollution and CRP. In a cross-sectional study 
conducted in a representative sample of the 
English population (Forbes et al. 2009), no 
association was observed between CRP and 
PM10 or NO2. Fibrinogen was not associated 
with air pollution either. In the study, disper-
sion models were used to estimate air pollu-
tion concentrations for the centroid (1 km2) 
of each postcode sector; the same exposure 
estimate was assigned to all study participants 
within the sector. The spatial resolution of 
exposure assessment was higher in the present 
study, which might explain the discrepancy 
concerning CRP. In a German study that used 
the HNR cohort and dispersion models, PM2.5 
was found to be associated with CRP in men 
but not in women (Hoffmann et al. 2009). In 
the present study, PM2.5 was associated with 
CRP in the HNR cohort in men and women 
combined. In an earlier cross-sectional study 
conducted in Stockholm, Sweden (Panasevich 
et al. 2009), there was some evidence for an 
association between dispersion-modeled long-
term NO2 concentration and CRP, but not 
for fibrinogen, among adults (45–70 years 
of age). In the same study, NO2 was also 
associated with another marker of systemic 
inflammation, interleukin-6. In a cross-
sectional study conducted in a representative 
sample of adults ≥ 54 years of age in Taiwan 
(Chuang et al. 2011), long-term PM10, PM2.5, 
and NO2 concentrations were all associated 
with interleukin-6.
Fibrinogen is a hemostatic factor with 
proinflammatory properties. It has been 
shown that inflammatory and coagulatory 
processes are intertwined via many molecular 
mechanisms, and typically systemic inflam-
mation is associated with increased levels 
of fibrinogen (Davalos and Akassoglou 
2012). One previous cross-sectional study, 
conducted in a representative sample of the 
U.S. population (Schwartz 2001), had data 
on fibrinogen but not on CRP. Both NO2 
and PM10 were found to be associated with 
fibrinogen as well as with platelet counts. In 
the present study, fibrinogen was not associ-
ated with the studied pollutants. Compared 
with CRP, there were fewer observations 
(17,428 vs. 22,561) and lower variability in 
concentrations—both factors that reduce the 
chance of identifying associations.
The most robust association in the present 
study was observed between traffic intensity at 
the road nearest to home and CRP. Cohort 
participants living on a busy road (> 10,000 
vehicles/day) had significantly increased CRP 
compared with participants living on a quiet 
residential street (< 1,000 vehicles/day). The 
estimated increase was modest (10.2%), but 
can be seen as clinically significant consid-
ering that CVD risk seems to increase linearly 
with increasing CRP (Ridker and Cook 
2004). It is noteworthy that increased CRP 
concentration is not necessarily a causal factor 
in the development of CVD, but might only 
be an indicator of an increased risk. No statis-
tically significant association was observed 
between CRP levels and traffic load within 
100 m on major roads, another indicator of 
proximity to dense traffic, perhaps because 
traffic intensity at the nearest road indicates 
better exposure to fresh traffic exhaust. An 
earlier cross-sectional study conducted among 
adult Puerto Ricans (45–75 years of age) 
has reported an association between living 
within 100 m from busy roads (> 20,000 
vehicles/day) and CRP (Rioux et al. 2010). 
In the present study, positive but statistically 
nonsignificant effect estimates were observed 
for high traffic load.
Inhalation of particulate air pollution is 
known to cause pulmonary oxidative stress 
and pulmonary inflammation (Brook et al. 
2010), which in turn has been hypothesized 
to lead further to systemic inflammation. It 
has been recently shown that oxidative poten-
tial of particles sampled near major streets 
is several times higher than of particles at 
urban background locations (Boogaard et al. 
2012). Systemic inflammation and impaired 
endothelial function provide a plausible link 
between exposure to traffic-related pollut-
ants and CVD. Systemic inflammation plays 
Figure 1. Cohort-specific and pooled effect estimates (the main model) for the associations of NOx and 
traffic with inflammatory markers. veh, vehicles. Estimates calculated for a 20-μg/m3 increase in NOx. 
(A) NOx, traffic intensity at the nearest road, and CRP; (B) NOx, traffic load on major roads within 100 m, 
and fibrinogen.
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a major role in the development of athero-
sclerosis, possibly leading, over time, to 
clinically detectable CVD (Libby et al. 2002). 
Acute increases in the inflammatory response 
and the development of vulnerable arterial 
plaque may in turn lead to acute exacerba-
tions of CVD. An increasing number of 
studies link either traffic-related pollutants or 
traffic intensity with the prevalence, and even 
incidence, of CVD (Brook et al. 2010).
Most of the evidence on the health 
effects of PM relates to cardiorespiratory 
health. However, some recent studies have 
associated long-term PM exposure with 
additional outcomes such as rheumatoid 
arthritis, diabetes, cognitive impairment, and 
leukemia (Amigou et al. 2011; Hart et al. 
2009; Krämer et al. 2010; Ranft et al. 2009). 
Importantly, an inflammatory component 
is part of the pathogenesis of many major 
noncommunicable diseases such as diabetes, 
Alzheimer’s disease, and cancer (Mantovani 
et al. 2008; Sardi et al. 2011). This adds to 
the importance of evaluating links between 
exposure to air pollution from local traffic 
and systemic inflammation.
As part of the large European ESCAPE 
project, this study has some major strengths, 
including the large number of observations, a 
multi-city study design covering many types of 
exposure environments and climates, rigorous 
exposure assessment including extensive quality 
control measures, and the use of common 
study manuals for exposure assessment, data 
management, and data analyses. An obvious 
limitation is the cross-sectional nature of the 
study. However, a large number of individual-
level and some neighborhood-level covariates 
were available for inclusion in the statistical 
models to reduce confounding. It was unfor-
tunate that data on individual-level income, a 
quantitative indicator of socioeconomic status, 
was not available. However, we believe that 
residual confounding by individual level socio-
economic status would have been substantially 
reduced by adjusting for educational level and 
lifestyle factors including smoking. The asso-
ciation between traffic intensity at the road 
nearest to home and CRP was not sensitive 
to model specifications, which increases the 
plausibility of our main finding.
Other limitations include the retrospec-
tive nature of exposure assessment, varying 
LUR model performance for different air 
pollution components, and lack of data on 
personal exposures. Several recent studies 
have demonstrated that spatial variation in 
air pollution exposure can be reliably esti-
mated also retrospectively, even when overall 
mean levels may change over time (Eeftens 
et al. 2011; Gulliver et al. 2013). However, 
the differences in the accuracy of exposure 
assessment among pollutants should be taken 
into account when interpreting the present 
results. Therefore, even though no statisti-
cally significant associations were observed 
either for PM2.5 or coarse particles, the 
apparent lack of association for the latter 
could be attributable partly to the diffi-
culty of predicting concentrations. Finally, 
there is evidence that living close to traffic 
contributes significantly to personal exposures 
(Van Roosbroeck et al. 2008). Therefore, 
indices of traffic intensity near home can be 
considered as reasonable proxies for exposure 
to traffic-related air pollution. This is espe-
cially true for traffic intensity on the road 
nearest to home, because emissions occur 
close to exposed persons, so more complex 
physicochemical dispersion processes do not 
affect the concentrations.
Conclusions
Particulate air pollution was not associated 
with two markers of systemic inflammation 
in the present analysis. However, compared 
with levels in other participants, CRP levels 
were higher among those living next to 
a busy road. Therefore, the study provides 
some support for a mechanistic link between 
proximity to traffic and deteriorating cardio-
vascular health. Future research should aim 
at identifying air pollution components 
responsible for the association between traffic 
 intensity and systemic inflammation.
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